Objective: To measure serum Lp(a) concentrations in patients with T2D to investigate whether Lp(a) affects risk for DR.
D
iabetic retinopathy (DR) is one of the most unpleasant complications of diabetes and is a leading cause of blindness in the working-age population (1) . The issue of DR has aroused public concern in China because nearly 100 million Chinese adults have type 2 diabetes (T2D) (2) . The earliest preclinical event in the development of DR is unclear; thus, there is a need to implement effective strategies to prevent DR and to identify specific and early predictors.
The pathophysiology of DR is not completely understood, but various biochemical pathways have been implicated, including polyol accumulation (via the enzyme aldose reductase), accumulation of advanced glycation end products, formation of reactive oxygen species, and activation of protein kinase C (3, 4) . Interestingly, it has been demonstrated that atherogenic lipoproteins are also associated with DR (5, 6) .
Lipoprotein(a) [Lp(a)] consists of a low-density lipoprotein (LDL)-like particle with a lipid core and apolipoprotein B100 with a unique apolipoprotein (apolipoprotein A) tethered to the apolipoprotein B by a covalent disulfide bond. Previous observational studies have demonstrated that high serum Lp(a) concentrations are associated with a high risk for coronary heart disease (7), stroke (8) , vascular events (9) , and cardiovascular diseases (CVD) (10) .
Associations of T2D with a wide range of incident CVD have been suggested (11) . Interestingly, a variety of lipoprotein abnormalities have been described as being associated with this increased risk for CVD (12) . Malaguarnera et al. (13) found that Lp(a) concentrations were increased in a significant percentage of patients with retinopathy compared with those who had T2D without DR. Likewise, another study reported that serum Lp(a) concentrations were significantly raised in patients with DR compared with those without DR (14) . Furthermore, Heesen et al. (15) concluded that in patients with non-insuIin-dependent diabetes, higher Lp(a) concentrations were associated with a higher prevalence of DR. Thus, we hypothesize that serum Lp(a) concentration is associated with prevalence of DR. In this study of 377 Han Chinese patients with T2D, we measured the serum Lp(a) concentrations in patients with and without DR to investigate the relationship between Lp(a) and DR.
Patients and Methods
In this cross-sectional study, inpatients and outpatients with T2D aged 25 to 75 years were consecutively recruited from January 2014 to December 2015 at the Endocrinology Department of the Fourth Affiliated Hospital of Harbin Medical University in China. All participants were Han Chinese. Patients were excluded if they were aged .75 years, received hormone replacement therapy or other drugs affecting blood Lp(a) concentrations (such as niacin), or had any severe illness (such as unconsciousness, malignant tumor, renal insufficiency, or surgery or trauma in the preceding 3 months). Patients who had no light perception or severe visual impairment in both eyes or had a severe infection in one or both eyes were also excluded. This study was approved by the Fourth Affiliated Hospital of Harbin Medical University Ethics Committee and was performed according to the Declaration of Helsinki. Written informed consent was obtained from all participants before inclusion in the study.
At the beginning of the study, a detailed questionnaire was used to record the participants' information, including their sex, age, medical history (hypertension, hyperlipoproteinemia, and CVD events), current smoking status, use of medications (insulin, lipid-lowering treatment), and treatment of DR with panretinal photocoagulation or pars plana vitrectomy in either eye. In addition, height and weight were measured on admission to calculate the body mass index (BMI; defined as body weight divided by the square of body height). Furthermore, the retinopathy information obtained in history was confirmed by actual medical records.
We used the Canon CR6-45NM ophthalmic digital imaging system and a Canon EOS 10D digital camera (Canon, Tokyo, Japan) to obtain two digital images per eye through a nonpharmacologically dilated pupil (natural mesopic pupil). The images were examined by two investigators (W.J.T. and M.G.) who had undergone standard prejob training in DR diagnostic guidelines (Chinese version). A trained ophthalmologist (Dr. Lei Sun) from the Department of Ophthalmology of the Fourth Affiliated Hospital of Harbin Medical University was assigned to review images that were discrepant. Reliability analysis of the diagnoses (internal consistency) yielded a Cronbach a of 0.96 in the pilot study (n = 120). The DR examination was performed once, on the patient's admission. DR was defined as the presence of one or more retinal microaneurysms or retinal blot hemorrhages with or without more severe lesions. The severity of the DR was categorized according to the International Clinical Diabetic Retinopathy Severity Scale (ICDRSS) into one of the five following categories: no DR (group 1), mild nonproliferative DR (NPDR 1, group 2), moderate NPDR (NPDR 2, group 3), severe NPDR (NPDR 3, group 4), and proliferative DR (PDR, group 5) (16). The classification process was performed by two investigators (W.J.T. and M.G.) who were blinded to the clinical data. Diabetic macular edema (DME) was recorded as present or absent, classified as with or without clinically significant DME; vision-threatening DR (VTDR) was defined as the presence of PDR and/or DME.
For all patients, fasting blood samples were drawn at 0800 hours on the second morning after admission. After centrifugation for 20 minutes at 3000g at room temperature, serum samples were divided into aliquots and kept at 280°C until assay. Lp(a) concentrations were measured by using the immunoturbidimetric method with an Olympus AU2700 chemistry analyzer (Olympus, Tokyo, Japan). The intra-assay and interassay coefficients of variation were 1.2% to 2.0% and 1.5% to 2.7%, respectively. Other biomarkers were also measured, including hemoglobin A1c (HbA1c), high-sensitivity C-reactive protein (Hs-CRP), insulin, fasting blood glucose (FBG), creatinine, cholesterol, triglyceride, high-density lipoprotein cholesterol, LDL cholesterol (LDL-C), and urinary albumin excretion rate.
Results are expressed as percentages for categorical variables and as means (standard deviation) and medians [interquartile range (IQR)] for continuous variables, depending on whether the data were normally or non-normally distributed. ShapiroWilk tests were used to test for normality. Proportions were compared by using the x 2 test. A two-group comparison of non-normally distributed data were performed by using the Mann-Whitney U test, and a two-tailed Student unpaired t test was used for normally distributed continuous variables. Correlations among laboratory parameters were performed by using the Spearman rank correlation test. The relationship between serum Lp(a) concentration and DR or VTDR was evaluated by using univariate and multivariate regression analyses. For the univariate regression analysis, categorical variables [sex; hypertension; history of CVD; smoking; diabetic nephropathy; use of insulin, sulfonylurea, metformin, or lipidlowering medication; HbA1c (,7% or $7%)] and continuous variables [age, diabetes duration, BMI, estimated glomerular filtration rate, Hs-CRP, cholesterol, triglycerides, LDL-C, HDL-C and Lp(a)] were used as covariates. We used crude models and multivariate models adjusted for all significant predictors and report odds ratios (ORs). For multivariate analysis, we included confounders, known risk factors, and other predictors as assessed in univariate analysis. For a more detailed exploration of the association between Lp(a) and DR or VTDR, we used multivariate analysis models to estimate adjusted OR and 95% confidence intervals (CIs) for DR and VTDR for the different LP(a) quartiles, using the lowest Lp(a) quartile as a reference. Receiver-operating characteristic curves were used to test the overall prediction accuracy of Lp(a) and other markers to diagnose DR or VTDR, and results are reported as area under the curve (AUC). Finally, we divided the patients into four groups according to Lp(a) and HbA1c concentrations as follows: group 1, Lp(a) in quartiles 1 to 3 and HbA1c , 7%; group 2, Lp(a) in quartiles 1 to 3 and HbA1c $ 7%; group 3, Lp(a) in quartile 4 and HbA1c , 7%; group 4, Lp(a) in quartile 4 and HbA1c $ 7%.
Statistical analyses were performed with SPSS for Windows, version 22.0 (IBM, Chicago, IL) and the receiver operating characteristic R package (version 1.0-2), which is available from the Comprehensive R Archive Network repository (http:// cran.r-project.org/). Statistical significance was defined as P , 0.05.
Results

Patient characteristics
Of the 432 enrolled patients, 377 (87.3%) completed the study. Fifty-five enrolled patients were excluded from the study for the following reasons: Nine patients were aged .75 years, five received hormone replacement therapy, 10 received niacin, 25 had severe illness, and six had no light perception or severe visual impairment in eyes. However, the 377 patients who completed the study had baseline characteristics [age (P = 0.15), sex (P = 0.39), and BMI (P = 0.57)] similar to those of the initial cohort of 432 patients. At baseline, the study population consisted of 182 women (48.3%), an overall median age of 58 (IQR, 50 to 66) years, and a median duration of diabetes of 8.0 (IQR, 6.0 to 11.5) years. Thirty-two (8.5%) patients required panretinal photocoagulation or pars plana vitrectomy. The distribution of Lp(a) concentration was nonnormal (Shapiro-Wilk test, P = 0.04), and the median concentration was 27.0 (IQR, 14.3-45.6) mg/dL (Supplemental Fig. 1 ). The distribution of Lp(a) was skewed toward lower concentrations. Table 1 shows that the patients with DR were older (65 vs 55 years; P = 0.032); had a longer duration of diabetes (10.0 vs 6.5 years; P , 0.01); more frequent use of insulin (29.7 vs 18.8%; P = 0.024); and higher concentrations of HbA1c (P , 0.01), FBG (P , 0.01), and Lp(a) (P , 0.01) compared with those without DR. With regard to the Lp(a) quartile groups, patients with higher Lp(a) concentrations had higher concentrations of HbA1c (P for trend=0.009), FBG (P = 0.012), and Hs-CRP (P = 0.036). There were no differences in age, sex, BMI, diabetes duration, presence of hypertension or CVD, use of insulin or metformin, estimated glomerular filtration rate, LDL-C, and or high-density lipoprotein cholesterol according to baseline Lp(a) quartiles (P . 0.05) (Supplemental Table 1 (Fig. 1) . The distribution of Lp(a) concentration was positively skewed. Nonparametric Spearman rank correlation revealed a statistically significant positive correlation between serum Lp(a) concentration and ICDRSS group (r = 0.372; P , 0.001).
Lp(a) and DR
Among the participants with T2D, DR was found in 101 cases (26.8%). Serum Lp(a) concentrations were significantly higher in patients with DR than those without DR [43.9 (IQR, 25.9 to 77.7) mg/dL vs 23.8 (IQR, 12.9 to 37.7) mg/dL; P , 0.001] (Supplemental Fig. 1 ). The DR distribution across Lp(a) quartiles ranged from 11.7% (first quartile) to 47.9% (fourth quartile), with a P for trend , 0.001 (Fig. 2) .
Univariate logistic regression analysis revealed that age, diabetes duration, BMI, HbA1c, Hs-CRP, urinary albumin excretion, and Lp(a) were potential risk factors for DR. After adjustment for multiple confounding factors, the third and fourth Lp(a) quartiles were significantly associated with DR during the observation period compared with the first Lp(a) quartile (P , 0.05). Age, diabetes duration, BMI, high HbA1c, and Hs-CRP during the study were significant predictive factors for DR in the multivariable analysis (Table 2) .
With an AUC of 0.79 (95% CI, 0.72 to 0.85), Lp(a) showed a significantly greater ability to predict DR compared with Hs-CRP (AUC, 0.70; 95% CI, 0.64 to 0.75; P , 0.05), age (AUC, 0.59; 95% CI, 0.53 to 0.65; P , 0.001), and diabetes duration (AUC, 0.64; 95% CI 0.57 to 0.69; P , 0.01), but a similar ability to predict DR as HbA1c (AUC, 0.75; 95% CI, 0.70 to 0.82; P = 0.08) (Supplemental Fig. 2 ). Lp(a) improved the ability of HbA1c to diagnose DR (AUC of the combined model, 0.84; 95% CI, 0.79 to 0.90; P , 0.01). This improvement was stable in an internal fivefold cross-validation that resulted in an average AUC (standard error of the mean) of 0.75 (0.031) for HbA1c and 0.84 (0.022) for the combined model, corresponding to a difference of 0.09 (0.009).
Lp(a) and VDTR
Among the study participants, VTDR was found in 40 cases (10.6%). Serum Lp(a) concentrations were significantly higher in patients with DR than those without DR [48.9 (IQR, 30.2 to 98.3) mg/dL vs 22.4 (IQR, 11.5 to 34.2) mg/dL; P , 0.001]. The VTDR distribution across the Lp(a) quartiles ranged from 4.3% (first quartile) to 19.1% (fourth quartile), P for trend , 0.001 (Fig. 2) .
Univariate logistic regression analysis revealed that age, diabetes duration, BMI, HbA1c, Hs-CRP, and Lp(a) were potential risk factors for VTDR. After adjustment for multiple confounding factors, the third and fourth Lp(a) quartiles were significantly associated with DR during the observation period compared with the first quartile (P , 0.05). Age, diabetes duration, BMI, higher HbA1c, and Hs-CRP during the study were significant predictive factors for VTDR in the multivariable analysis (Table 2) . With an AUC of 0.82 (95% CI, 0.75 to 0.89), Lp(a) showed a significantly greater discriminatory ability to predict VTDR compared with Hs-CRP (AUC, 0.72; 95% CI, 0.68 to 0.75; P , 0.01), diabetes duration (AUC, 0.62; 95% CI, 0.56 to 0.69; P , 0.001), and HbA1c (AUC, 0.74; 95% CI, 0.68 to 0.80; P , 0.05) (Supplemental Fig. 3 ). In addition, a model containing known risk factors plus Lp(a) compared with a model containing known risk factors without Lp(a) showed a greater discriminatory ability to predict VTDR (P , 0.01).
Combining Lp(a) and HbA1c status to predict DR or VTDR Patients were categorized into four groups according to Lp(a) concentration and HbA1c status during the study. The patient group with highest concentrations of both Lp(a) (fourth quartile) and HbA1c ($7%) had an OR of 5.15 (95% CI, 2.78 to 9.55; P , 0.001) for DR compared with patients with lower concentrations of both factors. Even when the HbA1c level was ,7.0% during the observation period, the highest Lp(a) quartile group showed significantly increased risk for DR [OR, 2.48; 95% CI, 1.65 to 3.38; Fig. 3(a) ]. Similarly, the association between the progression of DR (defined as VDTR) and increased Lp(a) concentrations also achieved statistical significance in the patient group with highest concentrations of both Lp(a) (fourth quartile) and HbA1c ($7%) with an OR of 5.32 (95% CI, 2.92 to 10.15; P , 0.001) [ Fig. 3(b) ].
Discussion
This study showed that patients in the highest Lp(a) concentration quartile had a higher risk for DR and VTDR, regardless of whether glycemic control (HbA1c , 7.0%) was achieved during the observation period. Previous studies have shown associations between serum Lp(a) concentration and DR (16), NPDR (17) , and PDR (18, 19) . Similarly, we found a positive relationship between Lp(a) concentration and risk for DR or VTDR. The importance of maintaining strict glycemic control and having frequent retinal examinations should be expressed to patients with T2D, especially those with higher concentrations of Lp(a) (fourth quartile) and HbA1c ($7%). Furthermore, we found that serum Lp(a) concentrations were significantly associated with the severity of DR. Similarly, Chopra et al. (14) found that Lp(a) concentrations increased with increasing severity of DR. However, Cetin et al. (20) did not find any significant association between the severity of DR and serum lipid concentrations.
Lp(a) can affect vascular tone and perfusion, oxidize lipids, and enhance oxidative stress via the generation of reactive oxygen species and inflammatory actions on the vascular wall (21, 22) and has been associated with endothelial dysfunction (23) . Lp(a) might play a role in the potential association between DR and atherosclerosis and has been suggested to be an independent risk factor for diabetic microvascular complications (5) . Previous studies have shown that serum Lp(a) concentrations were significantly higher in patients with DR than those without DR (24, 25) , which is consistent with our findings. However, other studies did not find any difference between these two groups (26, 27) . Differences in participant samples, diagnostic and DR assessment methods, and time of assessment may explain these discrepancies.
The mechanisms behind the potential causal relationship between Lp(a) and retinopathy remain unclear. Lp(a) from blood may play a central, and heretofore unrecognized, role in propagating retinal injury. Although the association of serum Lp(a) with DR risk has yet to be properly explored, several possible mechanisms can be proposed. First, elevated Lp(a) concentrations may play a causative role in DR by damaging the microcirculation (28) . Some observations support the concept that plasma lipoproteins (which we can study relatively easily) may modulate disease risk, but extravasated lipoproteins are the direct mediators of DR (29) . Second, lipid peroxidation products activate the canonical wingless-type MMTV integration site (WNT) pathway through oxidative stress, which plays an important role in the development of retinal diseases (30). Zhou et al. (31) suggests that dysregulation of the WNT pathway in diabetes represents a new pathogenic mechanism of diabetic nephropathy. Third, endoplasmic reticulum stress markers and ORP150 chaperones are expressed in areas containing oxidized LDL in atherosclerotic lesions and are induced by oxidized LDL and oxidized lipids in cultured cells (32) . Oxidized LDL is known to be toxic to many cell types, including vascular and neural cells and may therefore perpetuate retinal injury. Another study indicated a protective effect of endoplasmic reticulum stress preconditioning against retinal endothelial inflammation, which likely occurs through activation of XBP1-mediated unfolded protein response and inhibition of nuclear factor-kB activation (33) . Lastly, Lp(a) is involved in the activation of acute inflammation, and circulating markers of inflammation may be related to more severe DR (34) .
Our study analyzed the association between Lp(a) concentration and DR in Chinese patients. This is an important distinction because circulating Lp(a) concentrations differ substantially among ethnic groups. Furthermore, we collected data on a wide range of potentially confounding risk factors, allowing us to estimate the independent effect of Lp(a). Finally, we chose a different strategy to previous studies in our use of Lp(a) quartiles and HbA1c dichotomies because we have found this strategy to be more sensitive to other factors that might influence biomarker concentrations.
Several limitations should be taken into account in interpreting the results of the current study. First, we could not measure the apo(a) isoforms and LP(a) genotypes at baseline. Second, Lp(a) concentrations vary significantly among different ethnic groups. This hospital-based cohort consisted of one Chinese ethnic group from a single treatment center. Third, Lp(a) has a wide range of plasma concentrations with a skewed deviation, and there is no standard Lp(a) assay method (16) . Fourth, systematic information on infections or other complications, such as deep venous thrombosis, that might infect Lp(a) concentrations, were not available. Last, as an observational study, no data about the management of patients' Lp(a) concentrations during follow-up were available. Thus, we could not determine whether any subsequent reductions in Lp(a) concentrations ameliorated DR events in our patients. Further controlled studies should be carried out to investigate whether lowering Lp(a) concentrations results in a reduction of DR risk. 
Conclusion
Despite these limitations, we propose that serum concentrations of Lp(a) are associated with DR and VDTR in Han Chinese patients with T2D, and strict glycemic control and more frequent retinal examinations should be recommended for patients in the highest Lp(a) quartile. Further studies should be carried out to investigate the cause of increased plasma Lp(a) concentrations and the precise role of Lp(a) in the pathology of DR.
